Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News - Page 19 of 29
-
Drug users under the microscope: Temo’s experience in Georgia
“I was in prison when I was diagnosed with Hepatitis B,” says Temo, 33. “I was just left with the...
-
Ukraine: First civil society organization to oppose Merck’s patent application ( MK-8591) on the grounds of “obviousness”
On 28 May 2019, 100 Percent Life (the Network) submitted an opposition to the Ukrainian Patent and Trademark Office against...
-
Politics of Death: The End of Brazil’s Department of AIDS
Adapted from a post published by ABIA, Global AIDS Policy Watch: A joint story from Brazilian NGOs that have denounced...
-
Pipeline patents – Brazilian Supreme Court decides on the present and the future
On Wednesday 22 May, the largest trial in the history of the Brazilian Federal Supreme Court (STF) involving the pharmaceutical...
-
Truvada for PrEP. Gilead grilled at US congressional hearing
The USA is being charged $70 per pill for a drug, yet tax payers largely funded the research. Thanks to...
-
What’s wrong with IP rights? Protecting medicines from competition can be costly
Gram for gram a HIV medicine costs more than gold. What makes drugs so costly? Is it research and development?...
-
Activists file post-grant opposition challenging a patent preventing purchase of cheaper treatment for hepatitis C
GTPI has presented an argument to the Brazilian Patent Office (INPI) to invalidate the patent granted for the drug daclatasvir....
-
Kularb’s story: Optimal treatment would reduce HIV-related stigma
Interview by Gemma Taylor. “I was told I’d have to wait for 10 more people to die before I could...
-
Advocacy in Ukraine results in drastic price reduction for HIV drug, raltegravir
The All-Ukrainian Network of People Living with HIV/AIDS (the Network) has received an official letter from Merck, dated 15 March...
-
Watching Brazil: In defence of democracy and human rights
Author: Andresa Porto – Political Scientist and member of GTPI. Now that the Brazilian government’s new party blocs have been...
-
Watching Brazil. New monthly column analyzing the impact of Bolsonaro’s politics on civil society and access to medicines
Author: Andresa Porto – Political Scientist and member of GTPI. Translated from Portuguese, original version here. This is the first...
-
Action against AbbVie. Money that could treat HIV patients ‘goes up in smoke’ in Kiev
Activists gathered outside a Kiev Court to highlight the huge amount of money being wasted on an overpriced drug, due...